Hematologic Malignancies

ASCO 2022

Questions discussed in this category

How do you now approach treatment sequencing in MM in light of the DETERMINATION trial data?

Do the results change your clinical practice?

2 Answers available

Papers discussed in this category

The New England journal of medicine, 2017-04-06

Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma.

The New England journal of medicine, 2019-05-30

Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma.

Blood,

Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial.

N Engl J Med, 2022 Jun 05

Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma.

Related Topics in Hematologic Malignancies